BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33166066)

  • 1. Identifying Minimal and Meaningful Change in a Patient-Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives.
    Bartlett SJ; Gutierrez AK; Andersen KM; Bykerk VP; Curtis JR; Haque UJ; Orbai AM; Jones MR; Bingham CO
    Arthritis Care Res (Hoboken); 2022 Apr; 74(4):588-597. PubMed ID: 33166066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis.
    Beaumont JL; Davis ES; Curtis JR; Cella D; Yun H
    J Rheumatol; 2021 Aug; 48(8):1239-1242. PubMed ID: 33722955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking.
    Bingham CO; Butanis AL; Orbai AM; Jones M; Ruffing V; Lyddiatt A; Schrandt MS; Bykerk VP; Cook KF; Bartlett SJ
    Rheumatology (Oxford); 2021 Sep; 60(9):4306-4314. PubMed ID: 33471127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.
    Saygin D; DiRenzo D; Raaphorst J; de Groot I; Bingham CO; Lundberg IE; Regardt M; Sarver C; de Visser M; Maxwell LJ; Beaton D; Kim JY; Needham M; Alexanderson H; Christopher-Stine L; Mecoli CA; Park JK;
    Semin Arthritis Rheum; 2024 Feb; 64():152339. PubMed ID: 38141522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of Functional Assessment of Chronic Illness Therapy-Fatigue to Patient-Reported Outcomes Measurement Information System Fatigue Scores in Two Phase III Baricitinib Rheumatoid Arthritis Trials.
    Bingham CO; Bartlett SJ; Kannowski C; Sun L; DeLozier AM; Cella D
    Arthritis Care Res (Hoboken); 2021 Apr; 73(4):481-488. PubMed ID: 31961494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis.
    Bingham Iii CO; Gutierrez AK; Butanis A; Bykerk VP; Curtis JR; Leong A; Lyddiatt A; Nowell WB; Orbai AM; Bartlett SJ
    J Patient Rep Outcomes; 2019 Feb; 3(1):14. PubMed ID: 30790155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ).
    Bartlett SJ; Bykerk VP; Schieir O; Valois MF; Pope JE; Boire G; Hitchon C; Hazlewood G; Bessette L; Keystone E; Thorne C; Tin D; Bingham CO;
    Qual Life Res; 2023 May; 32(5):1307-1318. PubMed ID: 36074252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritis.
    Rendas-Baum R; Lin X; Kosinski M; Bjorner JB; Bracher MG; Chen WH
    J Patient Rep Outcomes; 2024 Jan; 8(1):9. PubMed ID: 38252223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Validity and Responsiveness of PROMIS Health Domains Among Patients Presenting for Anterior Cervical Spine Surgery.
    Purvis TE; Andreou E; Neuman BJ; Riley LH; Skolasky RL
    Spine (Phila Pa 1976); 2017 Dec; 42(23):E1357-E1365. PubMed ID: 28742757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardizing fatigue measurement in multiple sclerosis: the validity, responsiveness and score interpretation of the PROMIS SF v1.0 - Fatigue (MS) 8a.
    Kamudoni P; Johns J; Cook KF; Salem R; Salek S; Raab J; Middleton R; Henke C; Repovic P; Alschuler K; von Geldern G; Wundes A; Amtmann D
    Mult Scler Relat Disord; 2021 Sep; 54():103117. PubMed ID: 34256350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis.
    Bartlett SJ; Orbai AM; Duncan T; DeLeon E; Ruffing V; Clegg-Smith K; Bingham CO
    PLoS One; 2015; 10(9):e0138543. PubMed ID: 26379233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.
    Orbai AM; Coates LC; Deodhar A; Helliwell PS; Ritchlin CT; Leibowitz E; Kollmeier AP; Hsia EC; Xu XL; Sheng S; Jiang Y; Liu Y; Han C
    Patient; 2022 Nov; 15(6):657-668. PubMed ID: 35768650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness and minimal important change of seven PROMIS computerized adaptive tests (CAT) in patients with advanced chronic kidney disease.
    Terwee CB; van der Willik EM; van Breda F; van Jaarsveld BC; van de Putte M; Jetten IW; Dekker FW; Meuleman Y; van Ittersum FJ
    J Patient Rep Outcomes; 2023 Apr; 7(1):35. PubMed ID: 37016107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Patient-Reported Outcomes Measurement Information System Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus.
    Jones JT; Carle AC; Wootton J; Liberio B; Lee J; Schanberg LE; Ying J; Morgan DeWitt E; Brunner HI
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):133-142. PubMed ID: 27111350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminant Ability, Concurrent Validity, and Responsiveness of PROMIS Health Domains Among Patients With Lumbar Degenerative Disease Undergoing Decompression With or Without Arthrodesis.
    Purvis TE; Neuman BJ; Riley LH; Skolasky RL
    Spine (Phila Pa 1976); 2018 Nov; 43(21):1512-1520. PubMed ID: 29621093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Rheumatoid Arthritis Disease Activity With Patient-Reported Outcomes Measurement Information System Measures Using Digital Technology.
    Yun H; Nowell WB; Curtis D; H Willig J; Yang S; Auriemma M; Chen L; Filby C; Curtis JR
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):553-560. PubMed ID: 30927515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.
    Bingham CO; Black S; Shiff NJ; Xu S; Langholff W; Curtis JR
    Rheumatol Ther; 2023 Jun; 10(3):659-678. PubMed ID: 36820983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Patient-Reported Outcomes Measurement Information System 29-Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus.
    Katz P; Pedro S; Michaud K
    Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1312-1321. PubMed ID: 28029753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients With Rheumatoid Arthritis.
    Crins MHP; Terwee CB; Westhovens R; van Schaardenburg D; Smits N; Joly J; Verschueren P; Van der Elst K; Dekker J; Boers M; Roorda LD
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1550-1559. PubMed ID: 31562795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Responsiveness of the PROMIS Pain Interference Short Forms With Legacy Pain Measures: Results From Three Randomized Clinical Trials.
    Chen CX; Kroenke K; Stump T; Kean J; Krebs EE; Bair MJ; Damush T; Monahan PO
    J Pain; 2019 Jun; 20(6):664-675. PubMed ID: 30529442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.